doi: 10.1016/j.bulcan.2017.06.001.
Epub 2017 Jul 5.
[2017 ASCO: Complete androgen blockade strikes back]
[Article in
French]
Affiliations
- PMID: 28688745
- DOI: 10.1016/j.bulcan.2017.06.001
Item in Clipboard
[2017 ASCO: Complete androgen blockade strikes back]
[Article in
French]
Bull Cancer.
2017 Jul-Aug.
No abstract available
Keywords: Abiraterone; Abiratérone; Blocage androgénique complet; Cancer de la prostate; Complete androgen blockade; Hormonal therapy naïve; Hormono-naïf; Prostate cancer.
Similar articles
-
Treating Patients with Metastatic Castration Resistant Prostate Cancer: A Comprehensive Review of Available Therapies.J Urol. 2015 Dec;194(6):1537-47. doi: 10.1016/j.juro.2015.06.106. Epub 2015 Jul 18. J Urol. 2015. PMID: 26196735 Review.
-
New agents in the arsenal to fight castrate-resistant prostate cancer.Curr Oncol Rep. 2013 Jun;15(3):239-48. doi: 10.1007/s11912-013-0305-9. Curr Oncol Rep. 2013. PMID: 23440553 Review.
-
First-line management of metastatic castrate-resistant prostate cancer patients: Audit of real-life practices.Bull Cancer. 2017 Jun;104(6):552-558. doi: 10.1016/j.bulcan.2017.02.002. Epub 2017 Apr 5. Bull Cancer. 2017. PMID: 28390646
-
Metastatic Castration-resistant Prostate Cancer: Piling Up the Benefits of Chemotherapy.Eur Urol. 2015 Aug;68(2):236-7. doi: 10.1016/j.eururo.2014.05.030. Epub 2014 Jun 5. Eur Urol. 2015. PMID: 24908474 No abstract available.
-
[Management of metastatic castration-resistant prostate cancer following docetaxel].Bull Cancer. 2012 Jul;99 Suppl 1:S66-72. doi: 10.1684/bdc.2012.1560. Bull Cancer. 2012. PMID: 22516457 Review. French.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
